Extracorporeal Membrane Oxygenation Support in COVID-19 Patients: A Propensity Score Analysis.

Chest Drainage Therapy: What Comes out of Pandora's Box Can Affect Patient Outcomes.

Identification of Lung Transplant Recipients With a Survival Benefit After Fundoplication.

Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience.

Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice.

Geographic disparities in lung transplantation in the United States before and after the November 2017 allocation change.

One Year Into the Pandemic: Evolving COVID-19 Outcomes in Lung Transplant Recipients, a Single-center Experience.

Early Mobilization during Extracorporeal Membrane Oxygenation for Cardiopulmonary Failure in Adults: Factors Associated with Intensity of Treatment.

Lung transplantation disparities based on diagnosis for patients bridging to transplant on extracorporeal membrane oxygenation.

Fundoplication after lung transplantation in patients with systemic sclerosis-related end-stage lung disease.

The Evolution of the Use of Extracorporeal Membrane Oxygenation in Respiratory Failure.

The authors reply.

Technical Aspects of Lung Volume Reduction Surgery Including Anesthetic Management and Surgical Approaches.

Geographic Differences in Lung Transplant Volume and Donor Availability During the COVID-19 Pandemic.

Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019: Crisis Standards of Care.